Ryvu Therapeutics Competitors and Similar CompaniesClear all

Ryvu Therapeutics's competitors and similar companies include Oncolines, Capella BioScience, Kleo and Gene Techno Science.

	Ryvu Therapeutics Ryvu Therapeutics is a biopharmaceutical company that develops drugs or treatments in oncology.	Oncolines Oncolines is a precision medicine services company in oncology and cancer immunotherapy.	Capella BioScience Computational Pharmaceutical Development.	Kleo Kleo is a company that specializes in immunotherapy.	Gene Techno Science Gene Techno Science is a developer of drugs for cancer and other rare and intractable diseases.
Founding Date	Founding Date 2007	Founding Date 2021	Founding Date 2014	Founding Date 2015	Founding Date 2001
Type	Type Public	Type Subsidiary	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare drug development oncology	Tags Healthcare drug development oncology	Tags Healthcare drug development oncology	Tags Healthcare drug development oncology	Tags Healthcare drug development oncology
Locations	Locations Kraków, PL HQ Kraków, PL	Locations Oss, NL HQ	Locations Greater London, GB HQ	Locations New Haven, US HQ	Locations Chuo City, JP HQ
Employees	Employees 32819% increase	Employees 21	Employees N/A	Employees 224% decrease	Employees 38
Financial
Revenue (est.)	Revenue (est.) zł62.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥5.1b (FY, 2025)
Cost of goods	Cost of goods zł113.3m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥3.4b (FY, 2025)
Gross profit	Gross profit (zł25.6m) (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥1.6b (FY, 2025)
Net income	Net income (zł101.2m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income (¥21.1m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 15.5m	Total funding raised $ 32m	Total funding raised $ 13.1m